依据既往经验，口服磷酸盐结合剂有助于治疗系统性继发性甲旁亢。
Historically, treatment with oral phosphate binders was intended to prevent symptomatic secondary hyperparathyroidism.
结果糖尿病肾病、高龄、超滤量大、继发性甲旁亢的患者发生低血压的比例明显增加。
Results Diabetic Kidney disease, the elderly, UF quantity big, the secondary of secondary hyperparathyroidism in patients with marked increase in ratio of low blood pressure.
目的：研究小剂量口服罗盖全治疗慢性肾衰竭（CRF）继发性甲旁亢（SHPT）早期患者的疗效和副作用。
Objective:To study the curative effect and side-effect of low doses of oral calcitriol on early secondary hyperparathyroidism(SHPT) associated with chronic renal failure(CRF).
应用推荐